Syntaxin: A Protein Key To Cellular Processes (P44584)

Target Name: Syntaxin

NCBI ID: P44584

Syntaxin

Other Name(s): Stx | Syntaxin

Syntaxin: A Protein Key To Cellular Processes

Syntaxin, also known as nonspecified subtype (Stx), is a protein that is expressed in various tissues throughout the body. It is a key component of the cytoskeleton and plays a critical role in the structure and function of cells. Syntaxin is also a drug target and has been identified as a potential biomarker for several diseases.

Syntaxin is a member of the glycine kinase (GK) family, which is a group of transmembrane proteins that regulate various cellular processes. The GK family is characterized by the presence of a catalytic active site, a regulatory subunit, and a C-terminal hypervariable region (HVR).

Syntaxin is a 21-kDa protein that is expressed in various tissues, including muscle, heart, brain, and cervical cancer. It is primarily localized to the cytoskeleton, where it plays a critical role in the structure and function of cells. Syntaxin is involved in the regulation of cell division, differentiation, and cytoskeletal organization.

One of the most significant functions of Syntaxin is its role in cell division. Syntaxin is involved in the regulation of mitosis, meiosis, and cell division in various tissues. During mitosis, Syntaxin helps to maintain the proper structure of the cytoskeleton and ensures that the chromosomes are correctly divided. During meiosis, Syntaxin helps to regulate the formation of chromosomes and the proper separation of homologous pairs.

Syntaxin is also involved in the regulation of cytoskeletal organization. It helps to maintain the integrity of the cytoskeleton and ensures that the cell maintains its shape and structure. This is important for various cellular processes, including cell movement, differentiation, and cytokinesis.

In addition to its role in cell division and cytoskeletal organization, Syntaxin is also involved in the regulation of several other cellular processes. It is involved in the regulation of cell adhesion, migration, and the association of intracellular signaling pathways with the cytoskeleton. Syntaxin also plays a role in the regulation of ion channels and their activities, as well as in the regulation of various signaling pathways that are involved in cell survival and proliferation.

Syntaxin is also a potential drug target. Its role in the regulation of cellular processes makes it an attractive target for the development of new pharmaceuticals. Several studies have shown that inhibiting Syntaxin can lead to the inhibition of various cellular processes that are involved in cancer growth and progression. This suggests that Syntaxin may be an effective target for cancer treatment.

In addition to its potential as a drug target, Syntaxin is also a potential biomarker for several diseases. Its role in the regulation of cellular processes makes it an attractive target for the development of new diagnostic tests. Several studies have shown that the levels of Syntaxin have been altered in various diseases, including cancer, neurodegenerative diseases, and developmental disorders. This suggests that Syntaxin may be a useful biomarker for these diseases.

Overall, Syntaxin is a protein that is involved in the regulation of various cellular processes that are critical for cell survival and growth. Its potential as a drug target and biomarker makes it an attractive target for further research in the field of cellular biology. Further studies are needed to fully understand the role of Syntaxin in the regulation of cellular processes and its potential as a drug and biomarker.

Protein Name: Syntaxin (nonspecified Subtype)

The "Syntaxin Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Syntaxin comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets